Li S - Search Results

1

Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis.

Liu X, Li S, Ke L, Cui H. Liu X, et al. Among authors: li s. BMC Cancer. 2024 Apr 17;24(1):490. doi: 10.1186/s12885-024-12256-z. BMC Cancer. 2024. PMID: 38632528 Free PMC article.

2

Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-Analysis.

Cui H, Li Y, Li S, Liu G. Cui H, et al. Among authors: li s, li y. Front Oncol. 2021 Aug 18;11:693886. doi: 10.3389/fonc.2021.693886. eCollection 2021. Front Oncol. 2021. PMID: 34490091 Free PMC article.

3

Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis.

Cui H, Li Y, Li S, Liu G. Cui H, et al. Among authors: li s, li y. Cancer Med. 2023 Jan;12(1):99-110. doi: 10.1002/cam4.4935. Epub 2022 Jun 12. Cancer Med. 2023. PMID: 35692190 Free PMC article.

4

Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis.

Zhong Y, Huo H, Dai S, Li S. Zhong Y, et al. Among authors: li s. Front Oncol. 2022 Aug 18;12:964779. doi: 10.3389/fonc.2022.964779. eCollection 2022. Front Oncol. 2022. PMID: 36059696 Free PMC article.

5

The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.

Ke L, Li S, Cui H. Ke L, et al. Among authors: li s. BMC Cancer. 2022 Nov 17;22(1):1185. doi: 10.1186/s12885-022-10284-1. BMC Cancer. 2022. PMID: 36397030 Free PMC article.

6

Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials.

Huang D, Ke L, Cui H, Li S. Huang D, et al. Among authors: li s. BMC Cancer. 2023 May 24;23(1):474. doi: 10.1186/s12885-023-10960-w. BMC Cancer. 2023. PMID: 37226111 Free PMC article.

7

Aortic dissection induced by vascular endothelial growth factor inhibitors.

Dai S, Zhong Y, Cui H, Zhao J, Li S. Dai S, et al. Among authors: li s. Front Pharmacol. 2023 Jun 22;14:1189910. doi: 10.3389/fphar.2023.1189910. eCollection 2023. Front Pharmacol. 2023. PMID: 37426822 Free PMC article. Review.

8

The predictive value of tumor mutation burden on survival of gastric cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Ke L, Li S, Huang D. Ke L, et al. Among authors: li s. Int Immunopharmacol. 2023 Nov;124(Pt B):110986. doi: 10.1016/j.intimp.2023.110986. Epub 2023 Sep 23. Int Immunopharmacol. 2023. PMID: 37748223 Free article. Review.

9

Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.

Huang D, Ke L, Cui H, Li S, Sun F. Huang D, et al. Among authors: li s. BMC Womens Health. 2024 Jan 13;24(1):34. doi: 10.1186/s12905-023-02879-y. BMC Womens Health. 2024. PMID: 38218775 Free PMC article.

10

Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis.

Kang Z, Jin Y, Yu H, Li S, Qi Y. Kang Z, et al. Among authors: li s. BMC Cancer. 2024 Jun 8;24(1):708. doi: 10.1186/s12885-024-12478-1. BMC Cancer. 2024. PMID: 38851684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,971 results

Search Page

Filters